These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9131944)

  • 1. Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens.
    Duffull SB; Kirkpatrick CM; Begg EJ
    Br J Clin Pharmacol; 1997 Feb; 43(2):125-35. PubMed ID: 9131944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
    Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
    Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
    Tod MM; Padoin C; Petitjean O
    Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: Antibiotic' nomogram and the SeBA-GEN and DoseCalc software programs.
    Mohan M; Batty KT; Cooper JA; Wojnar-Horton RE; Ilett KF
    Br J Clin Pharmacol; 2004 Nov; 58(5):521-7. PubMed ID: 15521900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing.
    Ryan AC; Carland JE; McLeay RC; Lau C; Marriott DJE; Day RO; Stocker SL
    Br J Clin Pharmacol; 2021 Mar; 87(3):1422-1431. PubMed ID: 32881037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.
    Nezic L; Derungs A; Bruggisser M; Tschudin-Sutter S; Krähenbühl S; Haschke M
    Eur J Clin Pharmacol; 2014 Jul; 70(7):829-37. PubMed ID: 24756148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General versus subpopulation values in Bayesian prediction of aminoglycoside pharmacokinetics in hematology-oncology patients.
    Radomski KM; Davis GA; Chandler MH
    Am J Health Syst Pharm; 1997 Mar; 54(5):541-4. PubMed ID: 9066862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily.
    Kirkpatrick CM; Duffull SB; Begg EJ
    Br J Clin Pharmacol; 1999 Jun; 47(6):637-43. PubMed ID: 10383541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside forecasting in neutropenic patients with cancer.
    Kosirog JL; Rospond RM; Destache C; Hall P
    Clin Pharmacokinet; 1993 Jan; 24(1):79-87. PubMed ID: 8448975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
    Cropp CD; Davis GA; Ensom MH
    Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.
    Hennig S; Holthouse F; Staatz CE
    Clin Pharmacokinet; 2015 Apr; 54(4):409-21. PubMed ID: 25403847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aminoglycosides in critically ill patients: individualization of dosage using Bayesian statistics and pharmacokinetic principles.
    Böttger HC; Oellerich M; Sybrecht GW
    Ther Drug Monit; 1988; 10(3):280-6. PubMed ID: 3176103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?
    Barclay ML; Kirkpatrick CM; Begg EJ
    Clin Pharmacokinet; 1999 Feb; 36(2):89-98. PubMed ID: 10092956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Hartford nomogram in trauma surgery patients.
    Finnell DL; Davis GA; Cropp CD; Ensom MH
    Ann Pharmacother; 1998 Apr; 32(4):417-21. PubMed ID: 9562135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing dose prediction software used to manage gentamicin dosing.
    Wong C; Kumar SS; Graham GG; Begg EJ; Chin PK; Brett J; Ray JE; Marriott DJ; Williams KM; Day RO
    Intern Med J; 2013 May; 43(5):519-25. PubMed ID: 23279297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.